NasdaqCM - Nasdaq Real Time Price USD
Palvella Therapeutics, Inc. (PVLA)
26.11
-0.45
(-1.69%)
As of 1:30:44 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
Operating Cash Flow
-10,840
-10,840
-13,703
-14,840
Financing Cash Flow
87,089
87,089
5,000
9,566
End Cash Position
83,602
83,602
7,350
16,053
Issuance of Capital Stock
--
--
--
9,532
Issuance of Debt
78,434
78,434
--
--
Free Cash Flow
-10,840
-10,840
-13,703
-14,840
12/31/2022 - 1/2/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BCAX Bicara Therapeutics Inc.
15.36
-1.00%
SRZN Surrozen, Inc.
10.58
+7.03%
FBRX Forte Biosciences, Inc.
6.75
+12.87%
ELDN Eledon Pharmaceuticals, Inc.
3.3000
-1.79%
TECX Tectonic Therapeutic, Inc.
21.71
+11.11%
LGND Ligand Pharmaceuticals Incorporated
106.93
+1.11%
BNTC Benitec Biopharma Inc.
14.08
+3.07%
THRD Third Harmonic Bio, Inc.
5.13
-0.39%
IKNA Ikena Oncology, Inc.
1.2000
-0.83%
DNTH Dianthus Therapeutics, Inc.
21.03
-2.46%